TrialInternational journal of hematology2013

A phase I/II study of ofatumumab (GSK1841157) in Japanese and Korean patients with relapsed or refractory B-cell chronic lymphocytic leukemia.

Yoshiaki Ogawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.